SNDX
Syndax Pharmaceuticals IncCompany with tickers: SNDX
CIK
1395937
CUSIP
87164F105
Shares Outstanding
88,610,027
13F Activity (30d)
164 filings
161 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2020-02-04 | 2020-01-30 | |
| 8-K | 2020-02-10 | 2020-02-07 | |
| 8-K | 2020-02-20 | 2020-02-12 | |
| 8-K | 2020-03-03 | — | |
| 10-K | 2020-03-05 | 2019-12-31 | |
| 8-K | 2020-04-30 | — | |
| 8-K | 2020-05-04 | 2020-04-30 | |
| 10-Q | 2020-05-07 | 2020-03-31 | |
| 8-K | 2020-05-07 | — | |
| 8-K | 2020-06-09 | — | |
| 8-K | 2020-07-07 | 2020-07-06 | |
| 10-Q | 2020-08-06 | 2020-06-30 | |
| 8-K | 2020-08-06 | — | |
| 8-K | 2020-11-02 | — | |
| 10-Q | 2020-11-05 | 2020-09-30 | |
| 8-K | 2020-12-07 | — | |
| 8-K | 2020-12-09 | 2020-12-08 | |
| 8-K | 2021-02-05 | 2021-02-03 | |
| 8-K | 2021-03-08 | — | |
| 10-K | 2021-03-12 | 2020-12-31 | |
| 10-K/A | 2021-04-30 | 2020-12-31 | |
| 10-Q | 2021-05-11 | 2021-03-31 | |
| 8-K | 2021-05-11 | — | |
| 8-K | 2021-05-13 | — | |
| 8-K | 2021-08-09 | — | |
| 10-Q | 2021-08-09 | 2021-06-30 | |
| 8-K | 2021-09-15 | — | |
| 8-K | 2021-09-27 | 2021-09-24 | |
| 8-K | 2021-10-04 | — | |
| 10-Q | 2021-11-15 | 2021-09-30 | |
| 8-K | 2021-11-15 | — | |
| 8-K | 2021-12-09 | — | |
| 8-K | 2021-12-13 | 2021-12-11 | |
| 8-K | 2021-12-17 | 2021-12-15 | |
| 8-K | 2021-12-23 | 2021-12-22 | |
| 8-K | 2022-02-03 | 2022-02-02 | |
| 8-K | 2022-02-24 | 2022-02-22 | |
| 8-K | 2022-03-01 | — | |
| 10-K | 2022-03-01 | 2021-12-31 | |
| 10-Q | 2022-05-09 | 2022-03-31 | |
| 8-K | 2022-05-09 | — | |
| 8-K | 2022-05-11 | — | |
| 8-K | 2022-06-13 | 2022-06-08 | |
| 8-K | 2022-08-08 | — | |
| 10-Q | 2022-08-08 | 2022-06-30 | |
| 8-K | 2022-09-23 | 2022-09-19 | |
| 10-Q | 2022-11-03 | 2022-09-30 | |
| 8-K | 2022-11-03 | — | |
| 8-K | 2022-12-05 | 2022-12-01 | |
| 8-K | 2022-12-07 | 2022-12-06 |
Showing 1–50 of 101 filings